These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut. Fujita Y; Asadi A; Yang GK; Kwok YN; Kieffer TJ Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G608-14. PubMed ID: 20185691 [TBL] [Abstract][Full Text] [Related]
5. Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue. Ugleholdt R Dan Med Bull; 2011 Dec; 58(12):B4368. PubMed ID: 22142579 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice. Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Atageldiyeva KK; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M Diabetologia; 2016 Mar; 59(3):533-41. PubMed ID: 26693710 [TBL] [Abstract][Full Text] [Related]
7. GIP1-39, a novel insulinotropic peptide form and aspects on its mechanism of action. Xie L; Lu J; Ostenson CG; Xu T; Chen ZW Regul Pept; 2004 Sep; 121(1-3):107-12. PubMed ID: 15256280 [TBL] [Abstract][Full Text] [Related]
8. K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Cho YM; Kieffer TJ Vitam Horm; 2010; 84():111-50. PubMed ID: 21094898 [TBL] [Abstract][Full Text] [Related]
9. Nesfatin-1 stimulates glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide secretion from STC-1 cells in vitro. Ramesh N; Mortazavi S; Unniappan S Biochem Biophys Res Commun; 2015 Jun; 462(2):124-30. PubMed ID: 25930999 [TBL] [Abstract][Full Text] [Related]
10. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666 [TBL] [Abstract][Full Text] [Related]
11. Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells. Pedersen J; Ugleholdt RK; Jørgensen SM; Windeløv JA; Grunddal KV; Schwartz TW; Füchtbauer EM; Poulsen SS; Holst PJ; Holst JJ Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E60-73. PubMed ID: 23115082 [TBL] [Abstract][Full Text] [Related]
12. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals. Jorsal T; Rhee NA; Pedersen J; Wahlgren CD; Mortensen B; Jepsen SL; Jelsing J; Dalbøge LS; Vilmann P; Hassan H; Hendel JW; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK Diabetologia; 2018 Feb; 61(2):284-294. PubMed ID: 28956082 [TBL] [Abstract][Full Text] [Related]
13. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents. Creutzfeldt W Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578 [TBL] [Abstract][Full Text] [Related]
14. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide. Meier JJ; Nauck MA Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Zhang Y; Huang S; Li P; Chen Q; Li Y; Zhou Y; Wang L; Kang M; Zhang B; Yang B; Dong X; Wu Y Cancer Lett; 2018 Sep; 431():190-200. PubMed ID: 29800682 [TBL] [Abstract][Full Text] [Related]
16. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Roberge JN; Brubaker PL Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572 [TBL] [Abstract][Full Text] [Related]
17. Extrapancreatic effects of GIP and GLP-1. Vella A; Rizza RA Horm Metab Res; 2004; 36(11-12):830-6. PubMed ID: 15655715 [TBL] [Abstract][Full Text] [Related]